EDGAR Filing Documents for 0001193125-06-055097

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-06-055097

Filing Date

2006-03-15

Accepted

2006-03-15 16:47:02

Documents

Period of Report

2005-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	895839
2	AMENDMENT NO. 2 TO COLLABORATION RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT	dex1025.htm	EX-10.25	17770
3	DESCRIPTION OF EXECUTIVE OFFICER ANNUAL INCENTIVE CASH COMPENSATION PROGRAM	dex1026.htm	EX-10.26	2434
4	LIST OF SUBSIDIARIES OF THE REGISTRANT	dex211.htm	EX-21.1	2055
5	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	dex231.htm	EX-23.1	1803
6	CERTIFICATION OF ULI HACKSELL, PH.D., CHIEF EXECUTIVE OFFICER	dex311.htm	EX-31.1	6676
7	CERTIFICATION OF THOMAS H. AASEN, CHIEF FINANCIAL OFFICER	dex312.htm	EX-31.2	6682
8	CERTIFICATION OF ULI HACKSELL, PH.D., CHIEF EXECUTIVE OFFICER	dex321.htm	EX-32.1	3987
9	CERTIFICATION OF THOMAS H. AASEN, CHIEF FINANCIAL OFFICER	dex322.htm	EX-32.2	4127
	Complete submission text file	0001193125-06-055097.txt		942774

Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121

Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871

ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)